Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Padma Narayanan"'
Autor:
Maria V Tsiper, Jennifer Sturgis, Larisa V Avramova, Shilpa Parakh, Raymond Fatig, Ana Juan-García, Nianyu Li, Bartek Rajwa, Padma Narayanan, C W Qualls, J Paul Robinson, V Jo Davisson
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e45226 (2012)
Early evaluation of new drug entities for their potential to cause mitochondrial dysfunction is becoming an important task for drug development. Multi-parametric high-content screening (mp-HCS) of mitochondrial toxicity holds promise as a lead in-vit
Externí odkaz:
https://doaj.org/article/b6c68ecb6bc142c08773a57eec5a927a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
ElenaAbbie DaleMaguire, Lankai Guo, Michael Byrne, Megan Cannon, Kris Taborn, Priyanka Shiva Prakasha, Kenneth Longo, Naoki Iwamoto, Pachamuthu Kandasamy, Mamoru Shimizu, Pochi Shum, Ashwini Ranade, Raghuvaran Iyer, Keith Bowman, Hailin Yang, Yuan Benny Yin, Fangjun Liu, Susovan Mohapatra, Lilia Macovei, Saurabh Patil, Janice Lansita, Xiao Shelley Hu, Karen Smith, Jaya Goyal, Padma Narayanan, Ken Rhodes, Michael Panzara, Chandra Vargeese
Publikováno v:
Alzheimer's & Dementia. 18
Autor:
Yanfeng Wang, Padma Narayanan, Daniel A. Norris, Richard S. Geary, Scott P. Henry, Tae-Won Kim, Brett P. Monia, Rosie Z. Yu
Publikováno v:
Nucleic Acid Therapeutics. 30:265-275
Inotersen (TEGSEDI™) is a 2'-O-(2-methoxyethyl)-modified antisense oligonucleotide, intended for treating hereditary transthyretin (TTR) amyloidosis with polyneuropathy. The potential immunogenicity (IM) response to inotersen was evaluated in chron
Autor:
Aldonis J Lusis, Wuxia Fu, Sebastien A. Burel, Richard G. Lee, Padma Narayanan, Jill Hsiao, Patrick Cauntay, Calvin Pan, Elaine Pirie, Rosanne M. Crooke, Shayoni Ray
Publikováno v:
Nucleic Acid Therapeutics. 29:266-277
Although antisense oligonucleotides (ASOs) are well tolerated preclinically and in the clinic, some sequences of ASOs can trigger an inflammatory response leading to B cell and macrophage activatio...
Autor:
Rosie Z, Yu, Yanfeng, Wang, Dan A, Norris, Tae-Won, Kim, Padma, Narayanan, Richard S, Geary, Brett P, Monia, Scott P, Henry
Publikováno v:
Nucleic acid therapeutics. 30(5)
Inotersen (TEGSEDI™) is a 2'
Autor:
Elaine, Pirie, Patrick, Cauntay, Wuxia, Fu, Shayoni, Ray, Calvin, Pan, Aldonis J, Lusis, Jill, Hsiao, Sebastien A, Burel, Padma, Narayanan, Rosanne M, Crooke, Richard G, Lee
Publikováno v:
Nucleic Acid Ther
Although antisense oligonucleotides (ASOs) are well tolerated preclinically and in the clinic, some sequences of ASOs can trigger an inflammatory response leading to B cell and macrophage activation in rodents. This prompted our investigation into th
Publikováno v:
Journal of Applied Polymer Science. 138:50838
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.